Doreen Rosenstrauch - Science and Medicine

Science and Medicine

Rosenstrauch accepted a position in the Texas Medical Center at the University of Texas Health Science Center at Houston in 1998. She continued her biomedical research on improving the biocompatibility of implantable cardiovascular devices such as left ventricular assist devices and stents utilising auricular chondrocytes, which are cells derived from the ear (cell therapy). She received funding from the National Science Foundation, National Institute of Health and the Roderick Duncan MacDonald foundation to further the scientific projects especially research in tissue engineering and gene therapy. She is holding adjunct appointments at the main Universities and Institutes in Houston. Rosenstrauch focusses on bridging the gap between science and medicine by creating an interdisciplinary environment for high school, undergraduate, graduate students and faculty members in the Texas Medical Center and internationally.

Rosenstrauch was invited by the People's Republic of China to chair a scientific session of the 14th World Congress of the World Society of Cardio-Thoracic Surgeons. In October 2004 in Beijing, China Rosenstrauch was meeting and collaborating with leaders in the field such as Dr. Zheng Qu, MD, PhD, Professor, Cardiac Surgery, Beijing Institute of Heart, Lung and Blood Vessels Disease and Dr. Denton Cooley, MD, President and Surgeon-in-Chief of the Texas Heart Institute and founder of St. Luke's Episcopal Hospital in Houston, Texas, USA, and Dr. O. H. Frazier, MD, Chief, Cardiopulmonary Transplantation at the Texas Heart Institute, Houston, Texas, USA).

Rosenstrauch is currently a physician scientist in the Texas Medical Center holding the following credentials: MD, PhD, RN, FAHA.